A Phase 4 interventional study of Long-Acting Local Anesthesia and Regional Anesthesia in Ankle Fractures, sponsored by Lahey Clinic. Recruiting at 1 site in United States. Open to participants aged 18 Years to 89 Years. Per ClinicalTrials.gov, last updated 2026-10-08.
Sponsored by Lahey Clinic · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 60 studies in Ankle Fractures with a site in United States — 16 open to participants now, 20 under way, none of them phase 3. Ankle Fractures · United States.
Among the 60 studies in Ankle Fractures with a site in United States, this one is the 22nd largest by planned enrollment of the 49 interventional ones that give a count, is one of 5 that started in 2020, is one of 6 in phase 4, reaches primary completion later than 15 of the 19 other live ones, and was the 29th registered.
203 studies on the registry are indexed under Ankle Fractures; 45 are open to participants now.
Browse Ankle Fractures studies →16 of the 60 studies in Ankle Fractures with a site in United States are open now. Recruiting first, the newest first:
Brian W. Noehren · Sites in United States
Ages 18–50
NYU Langone Health · Sites in United States
Ages 18–70
Jenna-Leigh Wilson · Sites in United States
Ages 18+
University of Kansas Medical Center · Sites in United States
Ages 18+
Maimonides Medical Center · Sites in United States
Ages 22+ · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 31 Ankle Fractures studies recruiting now, 14 (45%) set no upper age limit and 12 (39%) stop at 75 or younger; 4 take children under 18; 3 take healthy volunteers.
This study: 18 Years to 89 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
60 studies; the count open now beside each. This study's row is marked.
First in 1995; this study’s year is marked. 5 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 70 is below the median of 90 across 151 interventional studies indexed under Ankle Fractures.
Median enrollment 55 across the 49 interventional studies, 76 across the 11 observational. Of the 30 that completed or were terminated, 13 (43%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 60 have an industry lead sponsor. The 10 most frequent:
Lahey Clinic is the lead sponsor of 61 studies on the registry; 4 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 4 (80%) have results posted.
Lahey Clinic has 1 study filed under Ankle Fractures — fewer than ten, so there is no comparison to draw.
12 of the studies in Ankle Fractures with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05280639University of VirginiaSimplified Post Op Rehabilitation for Ankle and Pilon Fractures | 2026-12-01 |
| NCT06370325NYU Langone HealthNeuromuscular Electrical Stimulation in Foot and Ankle Surgery | 2026-12-30 |
| NCT04113044AO Innovation Translation CenterGo Fit Fast, Recovery Trajectory Using PROMIS®, Linking PROMIS® | 2026-12-31 |
| NCT06085586Maimonides Medical CenterFibulink Syndesmosis Repair System With Early Full-Weight Bearing | 2026-12-31 |
| NCT05729542University of California, San DiegoComparing Clinical Outcomes of Suture Button Versus Fibulink Fixation for Acute Ankle Syndesmosis Injuries | 2026-12-31 |
Add all 12 to your calendar (.ics) → With an account.
Among the 60 studies in Ankle Fractures with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This project is a multicenter, three armed, prospective randomized control trial studying the effectiveness of a long-acting local anesthetic "cocktail" in patients undergoing operative fixation of ankle fractures.
This study is a multicenter, three armed, prospective randomized control trial studying the effect of a long-acting local anesthetic "cocktail" in patients undergoing operative fixation of ankle fractures.
Primary Hypothesis Driven Aims:
Determine the effectiveness of a local anesthesia "cocktail" compared to regional block or standard of care in controlling pain in operatively treated ankle fractures. Nearly one out of ten fractures treated by both orthopaedic traumatologists and general orthopaedic surgeons taking call are ankle fractures. As such, effective pain control in this group of patients represents an opportunity to make a large impact, especially in the context of the current opioid epidemic. Improved pain control can help improve patient satisfaction, outcomes, decrease length of stay, cost of care, and complications associated with traditional narcotic use.
Determine the economic impact of cocktail and regional blocks in ankle fractures. A common concern with the use of regional blocks is the cost of the additional procedure, along with logistic delays which are associated with coordinating a separate procedure. This study would provide valuable data about the additional costs associated with regional blocks and with cocktail administration which could help aid in making economically conscious treatment decisions.
Secondary Aim:
Demonstrate the use of long-acting local anesthetic as a viable pain management strategy in fracture surgery. Although long-acting local anesthetics have an established track record in arthroplasty, there is a paucity of evidence guiding their use in fractures. Small case series in trauma and foot/ankle patients have been encouraging, but a rigorously conducted, prospective trial in a relatively homogeneous group could generate pilot data to validate the use of long acting local anesthetics in fracture surgery. This knowledge may be translatable to other extremity injuries as well, having a greater impact than the scope of the proposed trial.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Standard of care post-operative pain control with oral narcotics
Single injection perioperative peripheral nerve block + followed by administration of oral narcotics on a need-based system
Drug: Regional Anesthesia
Subcutaneous local cocktail injection + followed by administration of oral narcotics on a need-based system
Drug: Long-Acting Local Anesthesia
The cocktail consists of: * 0.5% Ropivicaine, 24.6 mL * Clonidine 100 mcg/mL, 0.4mL * Epinephrine 1mg/mL, 0.5mL * Saline to total volume of 50 mL (24.5mL of saline) The total amount of solution prepared is 50mL, but typically 30mL is used based on the size of the incision. The total volume administered will be recorded.
Also known as: Local Cocktail
0.5% ropivicaine - 30mL each sciatic and femoral/saphenous nerve, ultrasound guided
Also known as: Ropivicaine
Oral Narcotics / Morphine Milligram Equivalents (MME) given
The medical record (EPIC) will be used to determine the total morphine equivalents given to the patient post-surgery, including recovery unit administration of narcotics in the immediate post-operative period.
Time frame: 72 postoperative hours
Started Sep 2020 (actual). Primary completion is estimated for Sep 2027, 84 months after the start.
Primary completion moved once since we started tracking on Sep 25, 2026: Sep 2026 → Sep 2027, on Oct 8, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Lahey Clinic